Skip to main content

Scimagix Integrates Image Management Software with Amersham Platform

NEW YORK, Nov. 6-In a development partnership with Amersham Biosciences, Scimagix will retool its SIMS image management database for use with Amersham's IN Cell Analyzer 3000 screening platform, the company said yesterday.

 

Amersham's system can be used to monitor cellular processes as they are affected by drug candidates. It is designed to generate up to 30,000 cellular images per day.

 

Scimagix plans to adapt its database system so that image, annotation and analysis data generated by multiple Amersham platforms in one company can be integrated and organized in an automated fashion. Drug development researchers would be able to access cellular images and data with a web-based browser.

 

Financial details of this agreement were not reported.

 

According to Scimagix, one bottleneck in drug development arises because cell-based screening data tends to be isolated and fragmented. Its product is designed to centralize image-based data storage and mining process.

 

Scimagix is an informatics company based in San Mateo, Calif.

 

For further information, see the company website.

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.